SE305877B - - Google Patents

Info

Publication number
SE305877B
SE305877B SE11615/61A SE1161561A SE305877B SE 305877 B SE305877 B SE 305877B SE 11615/61 A SE11615/61 A SE 11615/61A SE 1161561 A SE1161561 A SE 1161561A SE 305877 B SE305877 B SE 305877B
Authority
SE
Sweden
Application number
SE11615/61A
Inventor
W Fruhstorfer
Calgan H Mueller
Original Assignee
Merck Ag E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Ag E filed Critical Merck Ag E
Publication of SE305877B publication Critical patent/SE305877B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE11615/61A 1960-11-23 1961-11-22 SE305877B (fa)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEM47194A DE1121054B (de) 1960-11-23 1960-11-23 Verfahren zur Herstellung eines neuen Imidazolinderivates und dessen Saeureadditionssalzen

Publications (1)

Publication Number Publication Date
SE305877B true SE305877B (fa) 1968-11-11

Family

ID=7305839

Family Applications (1)

Application Number Title Priority Date Filing Date
SE11615/61A SE305877B (fa) 1960-11-23 1961-11-22

Country Status (6)

Country Link
US (2) US3161653A (fa)
CH (1) CH446353A (fa)
DE (1) DE1121054B (fa)
FR (1) FR1614M (fa)
GB (1) GB951989A (fa)
SE (1) SE305877B (fa)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595234A1 (de) * 1965-04-27 1970-03-05 Roehm & Haas Gmbh Verfahren zur Herstellung oligomerer bzw. polymerer Amine
US3438995A (en) * 1968-01-08 1969-04-15 Melville Sahyun Diazaheterocyclic substituted benz-oxaheterocyclic compounds
GB1333471A (en) * 1971-01-27 1973-10-10 Labaz Imidazoline derivatives and process for preparing the same
US4978332A (en) * 1987-09-28 1990-12-18 Matrix Pharmaceutical, Inc. Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
WO1996032130A1 (en) * 1995-04-10 1996-10-17 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
WO1999032112A1 (en) * 1997-12-19 1999-07-01 Eli Lilly And Company Method for treating diabetes
BRPI0707315A2 (pt) * 2006-01-27 2011-05-03 Hoffmann La Roche uso de 2-imidazol substituìdo de derivados de imidazolina
AU2007312389B2 (en) * 2006-10-19 2012-02-23 F. Hoffmann-La Roche Ag Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
ES2381589T3 (es) * 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
BRPI0718054A2 (pt) * 2006-11-02 2013-11-05 Hoffmann La Roche 2-imidazóis substituídos como moduladores de receptores associados à traços de aminas
EP2084152A2 (en) * 2006-11-16 2009-08-05 F. Hoffmann-Roche AG Substituted 4-imidazoles
JP2010513238A (ja) * 2006-12-13 2010-04-30 エフ.ホフマン−ラ ロシュ アーゲー 微量アミン関連受容体(taar)に対するリガンドとしての新規2−イミダゾール
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
KR101174191B1 (ko) * 2007-02-02 2012-08-14 에프. 호프만-라 로슈 아게 중추 신경계 장애의 치료용 taar1 리간드로서 2-아미노옥사졸린
JP5130305B2 (ja) * 2007-02-15 2013-01-30 エフ.ホフマン−ラ ロシュ アーゲー Taar1リガンドとしての2−アミノオキサゾリン
CA2691082A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
JP2010531836A (ja) * 2007-07-03 2010-09-30 エフ.ホフマン−ラ ロシュ アーゲー 4−イミダゾリン及びそれらの抗うつ剤としての使用
AU2008281918A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands
WO2009016088A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
CA2695331A1 (en) * 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
MX2011000464A (es) * 2008-07-24 2011-03-01 Hoffmann La Roche Derivados de 4,5-dihidro-oxazol-2-ilo.
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
JP6814814B2 (ja) 2016-03-17 2021-01-20 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Taarのアゴニストとしての活性を有する5−エチル−4−メチル−ピラゾール−3−カルボキサミド誘導体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965648A (en) * 1960-12-20 Certain i-alkenyl benzimidazoles
DE1049387B (de) * 1959-01-29 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung eines neuen Imidazolins
US2441867A (en) * 1943-11-19 1948-05-18 Recip Ab Methods of producing 2-(alpha-naphthylmethyl)-imidazoline
US2457047A (en) * 1946-02-13 1948-12-21 Monsanto Chemicals 2-(2'-thenyl)-4, 5-dihydroimidazoles and process for making the same
US2780577A (en) * 1951-05-26 1957-02-05 Burroughs Wellcome Co Inhibiting polymethylene diquaternary curariform activity by alpha-stilbazoline derivatives
US2744909A (en) * 1955-06-27 1956-05-08 Bristol Lab Inc 2-(ortho-phenylbenzyl) imidazoline and acid addition salts
US3024248A (en) * 1956-09-18 1962-03-06 Ciba Pharm Prod Inc Organic sulfur compounds and method for producing same
US2955073A (en) * 1958-06-02 1960-10-04 Burroughs Wellcome Co Method of treating febrile convulsions
NL242891A (fa) * 1958-09-02
US3010972A (en) * 1960-03-18 1961-11-28 Smith Kline French Lab Condensed cyclopropyl amine derivatives
US3042674A (en) * 1960-07-12 1962-07-03 Sahyun Xanthene and thiaxanthene cyclic amidines

Also Published As

Publication number Publication date
DE1121054B (de) 1962-01-04
FR1614M (fr) 1962-12-17
GB951989A (en) 1964-03-11
US3238101A (en) 1966-03-01
CH446353A (de) 1967-11-15
US3161653A (en) 1964-12-15

Similar Documents

Publication Publication Date Title
FI40710B (fa)
FR846M (fa)
DE1424771A1 (fa)
BE601201A (fa)
BE599143A (fa)
SE305877B (fa)
BE600725A (fa)
BE680747A (fa)
BE645670A (fa)
BE607242A (fa)
BE606717A (fa)
BE600423A (fa)
BE606488A (fa)
BE600035A (fa)
BE603293A (fa)
BE603039A (fa)
BE599927A (fa)
BE599599A (fa)
BE599594A (fa)
BE599410A (fa)
BE601959A (fa)
BE599357A (fa)
BE601742A (fa)
BE599311A (fa)
BE601251A (fa)